IgA Vasculitis With Adalimumab Therapy for Hidradenitis Suppurativa: A Case Report and Review of Literature

Immunoglobulin A (IgA) vasculitis is a systemic vasculitis characterized by inflammation of the small vessels, with cutaneous, musculoskeletal, gastrointestinal, and renal involvement, usually seen in pediatric populations. Hidradenitis suppurativa is a chronic inflammatory disorder of the skin, whi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2022-10, Vol.14 (10)
Hauptverfasser: Alsulami, Sarah, Alotaibi, Rakan M, Alotaibi, Faisal F, Almatrafi, Faisal B, Filmban, Doaa M, Alneefia, Sultan, Alahmed, AhmedHusam, Hafiz, Waleed A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 10
container_start_page
container_title Curēus (Palo Alto, CA)
container_volume 14
creator Alsulami, Sarah
Alotaibi, Rakan M
Alotaibi, Faisal F
Almatrafi, Faisal B
Filmban, Doaa M
Alneefia, Sultan
Alahmed, AhmedHusam
Hafiz, Waleed A
description Immunoglobulin A (IgA) vasculitis is a systemic vasculitis characterized by inflammation of the small vessels, with cutaneous, musculoskeletal, gastrointestinal, and renal involvement, usually seen in pediatric populations. Hidradenitis suppurativa is a chronic inflammatory disorder of the skin, which can be treated by tumor necrosis factor-α (TNFα) inhibitor therapy. TNFα inhibitor therapy is used as an important milestone in the treatment of various rheumatological and autoimmune disorders. Unexpected adverse effects might occur. However, they are usually mild and do not warrant treatment withdrawal. We present a case of IgA vasculitis complicating adalimumab therapy for hidradenitis suppurativa. We also review and discuss similar cases reported in the literature.
doi_str_mv 10.7759/cureus.30122
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9644201</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2742916628</sourcerecordid><originalsourceid>FETCH-LOGICAL-c243t-5ebf14b61d8e36127d99b66ce8f74883101ce6cbfe29a060565adb51e0d74b6d3</originalsourceid><addsrcrecordid>eNpVkV9LwzAUxYsoOObe_AABX-1M0jZtfRDKUDcYCDr1MaTN7ZbZNTV_Jvv21m2IPt0D99zfPXCC4JLgcZom-U3lDXg7jjCh9CQYUMKyMCNZfPpHnwcja9cYY4JTilM8CD5mywK9CVv5Rjll0btyK1RI0aiN34gSLVZgRLdDtTZoqqQREtq98cV3nTfCqa24RQWaCAvoGTptHBKt7OVWwRfSNZor1yNcn-4iOKtFY2F0nMPg9eF-MZmG86fH2aSYhxWNIxcmUNYkLhmRGUSM0FTmeclYBVmdxlkWEUwqYFVZA80FZjhhiZBlQgDLtD-T0TC4O3A7X25AVtA6IxreGbURZse1UPz_plUrvtRbnrM4ppj0gKsjwOhPD9bxtfam7TNzmsY0J4zRrHddH1yV0dYaqH8_EMx_KuGHSvi-kugbEqeB-g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2742916628</pqid></control><display><type>article</type><title>IgA Vasculitis With Adalimumab Therapy for Hidradenitis Suppurativa: A Case Report and Review of Literature</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Alsulami, Sarah ; Alotaibi, Rakan M ; Alotaibi, Faisal F ; Almatrafi, Faisal B ; Filmban, Doaa M ; Alneefia, Sultan ; Alahmed, AhmedHusam ; Hafiz, Waleed A</creator><creatorcontrib>Alsulami, Sarah ; Alotaibi, Rakan M ; Alotaibi, Faisal F ; Almatrafi, Faisal B ; Filmban, Doaa M ; Alneefia, Sultan ; Alahmed, AhmedHusam ; Hafiz, Waleed A</creatorcontrib><description>Immunoglobulin A (IgA) vasculitis is a systemic vasculitis characterized by inflammation of the small vessels, with cutaneous, musculoskeletal, gastrointestinal, and renal involvement, usually seen in pediatric populations. Hidradenitis suppurativa is a chronic inflammatory disorder of the skin, which can be treated by tumor necrosis factor-α (TNFα) inhibitor therapy. TNFα inhibitor therapy is used as an important milestone in the treatment of various rheumatological and autoimmune disorders. Unexpected adverse effects might occur. However, they are usually mild and do not warrant treatment withdrawal. We present a case of IgA vasculitis complicating adalimumab therapy for hidradenitis suppurativa. We also review and discuss similar cases reported in the literature.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.30122</identifier><language>eng</language><publisher>Palo Alto: Cureus Inc</publisher><subject>Abdomen ; Allergy/Immunology ; Arthritis ; Case reports ; Creatinine ; Crohns disease ; Dermatology ; Emergency medical care ; Inflammatory bowel disease ; Laboratories ; Monoclonal antibodies ; Pain ; Patients ; Pediatrics ; Purpura ; Rheumatology ; Skin ; Steroids ; TNF inhibitors ; White people</subject><ispartof>Curēus (Palo Alto, CA), 2022-10, Vol.14 (10)</ispartof><rights>Copyright © 2022, Alsulami et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022, Alsulami et al. 2022 Alsulami et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c243t-5ebf14b61d8e36127d99b66ce8f74883101ce6cbfe29a060565adb51e0d74b6d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644201/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644201/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,27928,27929,53795,53797</link.rule.ids></links><search><creatorcontrib>Alsulami, Sarah</creatorcontrib><creatorcontrib>Alotaibi, Rakan M</creatorcontrib><creatorcontrib>Alotaibi, Faisal F</creatorcontrib><creatorcontrib>Almatrafi, Faisal B</creatorcontrib><creatorcontrib>Filmban, Doaa M</creatorcontrib><creatorcontrib>Alneefia, Sultan</creatorcontrib><creatorcontrib>Alahmed, AhmedHusam</creatorcontrib><creatorcontrib>Hafiz, Waleed A</creatorcontrib><title>IgA Vasculitis With Adalimumab Therapy for Hidradenitis Suppurativa: A Case Report and Review of Literature</title><title>Curēus (Palo Alto, CA)</title><description>Immunoglobulin A (IgA) vasculitis is a systemic vasculitis characterized by inflammation of the small vessels, with cutaneous, musculoskeletal, gastrointestinal, and renal involvement, usually seen in pediatric populations. Hidradenitis suppurativa is a chronic inflammatory disorder of the skin, which can be treated by tumor necrosis factor-α (TNFα) inhibitor therapy. TNFα inhibitor therapy is used as an important milestone in the treatment of various rheumatological and autoimmune disorders. Unexpected adverse effects might occur. However, they are usually mild and do not warrant treatment withdrawal. We present a case of IgA vasculitis complicating adalimumab therapy for hidradenitis suppurativa. We also review and discuss similar cases reported in the literature.</description><subject>Abdomen</subject><subject>Allergy/Immunology</subject><subject>Arthritis</subject><subject>Case reports</subject><subject>Creatinine</subject><subject>Crohns disease</subject><subject>Dermatology</subject><subject>Emergency medical care</subject><subject>Inflammatory bowel disease</subject><subject>Laboratories</subject><subject>Monoclonal antibodies</subject><subject>Pain</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Purpura</subject><subject>Rheumatology</subject><subject>Skin</subject><subject>Steroids</subject><subject>TNF inhibitors</subject><subject>White people</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpVkV9LwzAUxYsoOObe_AABX-1M0jZtfRDKUDcYCDr1MaTN7ZbZNTV_Jvv21m2IPt0D99zfPXCC4JLgcZom-U3lDXg7jjCh9CQYUMKyMCNZfPpHnwcja9cYY4JTilM8CD5mywK9CVv5Rjll0btyK1RI0aiN34gSLVZgRLdDtTZoqqQREtq98cV3nTfCqa24RQWaCAvoGTptHBKt7OVWwRfSNZor1yNcn-4iOKtFY2F0nMPg9eF-MZmG86fH2aSYhxWNIxcmUNYkLhmRGUSM0FTmeclYBVmdxlkWEUwqYFVZA80FZjhhiZBlQgDLtD-T0TC4O3A7X25AVtA6IxreGbURZse1UPz_plUrvtRbnrM4ppj0gKsjwOhPD9bxtfam7TNzmsY0J4zRrHddH1yV0dYaqH8_EMx_KuGHSvi-kugbEqeB-g</recordid><startdate>20221010</startdate><enddate>20221010</enddate><creator>Alsulami, Sarah</creator><creator>Alotaibi, Rakan M</creator><creator>Alotaibi, Faisal F</creator><creator>Almatrafi, Faisal B</creator><creator>Filmban, Doaa M</creator><creator>Alneefia, Sultan</creator><creator>Alahmed, AhmedHusam</creator><creator>Hafiz, Waleed A</creator><general>Cureus Inc</general><general>Cureus</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20221010</creationdate><title>IgA Vasculitis With Adalimumab Therapy for Hidradenitis Suppurativa: A Case Report and Review of Literature</title><author>Alsulami, Sarah ; Alotaibi, Rakan M ; Alotaibi, Faisal F ; Almatrafi, Faisal B ; Filmban, Doaa M ; Alneefia, Sultan ; Alahmed, AhmedHusam ; Hafiz, Waleed A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c243t-5ebf14b61d8e36127d99b66ce8f74883101ce6cbfe29a060565adb51e0d74b6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Abdomen</topic><topic>Allergy/Immunology</topic><topic>Arthritis</topic><topic>Case reports</topic><topic>Creatinine</topic><topic>Crohns disease</topic><topic>Dermatology</topic><topic>Emergency medical care</topic><topic>Inflammatory bowel disease</topic><topic>Laboratories</topic><topic>Monoclonal antibodies</topic><topic>Pain</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Purpura</topic><topic>Rheumatology</topic><topic>Skin</topic><topic>Steroids</topic><topic>TNF inhibitors</topic><topic>White people</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alsulami, Sarah</creatorcontrib><creatorcontrib>Alotaibi, Rakan M</creatorcontrib><creatorcontrib>Alotaibi, Faisal F</creatorcontrib><creatorcontrib>Almatrafi, Faisal B</creatorcontrib><creatorcontrib>Filmban, Doaa M</creatorcontrib><creatorcontrib>Alneefia, Sultan</creatorcontrib><creatorcontrib>Alahmed, AhmedHusam</creatorcontrib><creatorcontrib>Hafiz, Waleed A</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alsulami, Sarah</au><au>Alotaibi, Rakan M</au><au>Alotaibi, Faisal F</au><au>Almatrafi, Faisal B</au><au>Filmban, Doaa M</au><au>Alneefia, Sultan</au><au>Alahmed, AhmedHusam</au><au>Hafiz, Waleed A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IgA Vasculitis With Adalimumab Therapy for Hidradenitis Suppurativa: A Case Report and Review of Literature</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><date>2022-10-10</date><risdate>2022</risdate><volume>14</volume><issue>10</issue><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Immunoglobulin A (IgA) vasculitis is a systemic vasculitis characterized by inflammation of the small vessels, with cutaneous, musculoskeletal, gastrointestinal, and renal involvement, usually seen in pediatric populations. Hidradenitis suppurativa is a chronic inflammatory disorder of the skin, which can be treated by tumor necrosis factor-α (TNFα) inhibitor therapy. TNFα inhibitor therapy is used as an important milestone in the treatment of various rheumatological and autoimmune disorders. Unexpected adverse effects might occur. However, they are usually mild and do not warrant treatment withdrawal. We present a case of IgA vasculitis complicating adalimumab therapy for hidradenitis suppurativa. We also review and discuss similar cases reported in the literature.</abstract><cop>Palo Alto</cop><pub>Cureus Inc</pub><doi>10.7759/cureus.30122</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2022-10, Vol.14 (10)
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9644201
source PubMed Central Open Access; PubMed Central
subjects Abdomen
Allergy/Immunology
Arthritis
Case reports
Creatinine
Crohns disease
Dermatology
Emergency medical care
Inflammatory bowel disease
Laboratories
Monoclonal antibodies
Pain
Patients
Pediatrics
Purpura
Rheumatology
Skin
Steroids
TNF inhibitors
White people
title IgA Vasculitis With Adalimumab Therapy for Hidradenitis Suppurativa: A Case Report and Review of Literature
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T09%3A40%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IgA%20Vasculitis%20With%20Adalimumab%20Therapy%20for%20Hidradenitis%20Suppurativa:%20A%20Case%20Report%20and%20Review%20of%20Literature&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Alsulami,%20Sarah&rft.date=2022-10-10&rft.volume=14&rft.issue=10&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.30122&rft_dat=%3Cproquest_pubme%3E2742916628%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2742916628&rft_id=info:pmid/&rfr_iscdi=true